Saccharomyces Cerevisiae Fermentation Product Research Articles

Modulation of the acute phase response following a lipopolysaccharide challenge in pigs supplemented with an all-natural Saccharomyces cerevisiae fermentation product

This study was designed to determine if feeding a Saccharamyces cerevisiae fermentation product to weaned pigs would reduce the acute phase response (APR) following an lipopolysaccharide (LPS) challenge. Pigs (n = 20; 6.4 ± 0.2kg BW) were obtained and transported to a nursery facility. Pigs were housed individually with ad libitum access to feed and water. Pigs were weighed upon arrival and assigned to 1 of 2 treatment diets (n = 10 pigs/treatment) for 18 d: 1) non-medicated starter diet (Control); 2) Control diet + Saccharomyces cerevisiae fermentation product (XPC; 2kg/MT; Diamond V Original XPC™). Pigs were anesthetized on d 7 and 14 for insertion of an intraperitoneal (IP) temperature recording device and jugular catheter, respectively. On d 15, pigs were challenged i.v. with LPS (25µg/kg BW). Blood samples were collected at 0.5-h (serum) and 1-h (complete blood cell counts) intervals from −2 to 8h and at 24h relative to LPS challenge at 0h. There was a treatment effect (P ≤ 0.002) for serum TNF-α and IL-6 such that concentrations were greater in XPC-supplemented pigs than Control pigs (116.5 ± 5.0 vs. 90.9 ± 5.2pg/mL TNF-α; 188.3 ± 13.4 vs. 133.4 ± 11.7pg/mL IL-6; respectively) following LPS challenge. Administration of LPS increased IP temperature (P < 0.01), however, there was no effect of treatment (P = 0.12). Thus, feeding a Saccharamyces cerevisiae fermentation product to weaned pigs increased the pro-inflammatory cytokine response to an LPS challenge.

The effect of Saccharomyces cerevisiae on in vitro growth and fermentation of Selenomonas ruminantium and Megasphaera elsdenii

Stimulation of lactate utilization by Selenomonas ruminantium and Megasphaera elsdenii may help in reducing problems associated with rumen acidosis. The objective of this study was to determine the effect of a Saccharomyces cerevisiae live culture and Saccharomyces cerevisiae fermentation products on in vitro growth and fermentation of lactate-utilizing ruminal bacteria, S. ruminantium (ATCC 19205) and M. elsdenii (ATCC 25940). The cultures were run for 0, 6, 12, 24 and 48 h under anaerobic conditions on a growth medium supplemented with a yeast live culture (SC) or with yeast fermentation products (SCFP) and, as reference, on the same medium without supplementation (CON). Neither SC nor SCFP had a significant effect on the growth of S. ruminantium after 6, 12 and 24 h of incubation, but the live yeast culture significantly (P≤0.05) improved the growth of these bacteria after 48 h of incubation. The yeast fermentation products significantly (P≤0.05) decreased pH and increased lactate synthesis by S. ruminantium. The Saccharomyces cerevisiae live culture significantly improved the growth of M. elsdenii after 12 and 24 h of incubation, and the S. cerevisiae fermentation products increased its growth after 48 h. The After 24 and 48 h of incubation the Saccharomyces cerevisiae live culture reduced the concentration of total volatile fatty acids (VFA), while caproate was the main product of in vitro fermentation of M. elsdenii (P≤0.05). Saccharomyces cerevisiae live cultures may improve microbial fibre fermentation in the rumen by maintaining optimal pH conditions.

Short communication: Apparent ruminal synthesis of B vitamins in lactating dairy cows fed Saccharomyces cerevisiae fermentation product

Apparent ruminal synthesis and duodenal flow of thiamin, riboflavin, niacin, vitamin B6, folates, and vitamin B12 were evaluated in an experiment using 15 ruminally and duodenally cannulated lactating Holstein cows fed a basal diet, according to a crossover design, supplemented or not with 56 g/d of Saccharomyces cerevisiae fermentation product. Duration of the treatment period was 28 d. The basal ration had 28% neutral detergent fber, 30% starch and 16.5% crude protein; forages were corn silage (67% of forage dry matter) and alfalfa silage (33% of forage dry matter). Concentrations of B vitamins were analyzed in feed and duodenal digesta. Apparent ruminal synthesis of each B vitamin was calculated as the duodenal flow minus the intake. Under the present experimental conditions, a dietary supplement of Saccharomyces cerevisiae fermentation product had no effect apparent synthesis of B vitamins in the rumen or on the amounts of these vitamins reaching the duodenum and available for absorption by the dairy cow.

263 Effects of in-feed administration of a Saccharomyces cerevisiae fermentation product on the liver abscess microbiome and liver abscess rate in cattle reared to produce natural-branded beef

263 Effects of in-feed administration of a Saccharomyces cerevisiae fermentation product on the liver abscess microbiome and liver abscess rate in cattle reared to produce natural-branded beef

Influence of Saccharomyces cerevisiae fermentation products, SmartCare in milk replacer and Original XPC in calf starter, on the performance and health of preweaned Holstein calves challenged with Salmonella enterica serotype Typhimurium

This study was designed to investigate the effects of supplementing SmartCare (SC; Diamond V, Cedar Rapids, IA) in milk replacer and Original XPC (XPC; Diamond V) in calf starter on performance and health of preweaned calves following an oral challenge with Salmonella enterica. The study was performed in two 35-d periods with 30 Holstein bull calves (2 ± 1 d of age) per period. In each period, calves were blocked by location in the barn and randomly assigned to treatments that included control, base milk replacer and calf starter with no added Saccharomyces cerevisiae fermentation products; SC, milk replacer with 1 g of SC/calf per day and base calf starter; and SC+XPC, milk replacer with 1 g of SC/calf per day and calf starter with 0.5% XPC on a dry matter basis. Calves were fed 350 g of milk replacer solids at 14% dry matter twice daily at 0700 and 1700 h. Calf starter and water were offered ad libitum and intakes were recorded daily. Calves were challenged with 108 cfu of sulfamethazine-resistant Salmonella enterica serotype Typhimurium orally on d 14 of the study. Fecal Salmonella shedding was determined on d 14 to 21 (daily), 24, 28, and 35 using selective media. Blood samples were collected on d 0, 7, 14, 16, 18, 21, 24, 28, and 35 and analyzed for hematology; plasma were analyzed for haptoglobin concentrations. All data were reported as CON, SC, and SC+XPC, respectively. Calf starter intake was increased from d 22 to 35 among SC+XPC calves and from d 29 to 35 among SC calves. The SC+XPC calves had a lower neutrophil-to-lymphocyte ratio (0.81, 0.83, and 0.69 ± 0.051) throughout the study. The SC+XPC calves also had lower hematocrits (35.1, 35.3, and 33.4 ± 0.54%) and hemoglobin concentrations (10.8, 10.6, and 10.1 ± 0.16 mg/dL) throughout the study. We found a tendency for calves fed SC and SC+XPC to have more solid fecal scores during the week after the challenge. We observed no treatment or treatment × time differences on plasma haptoglobin concentrations (63, 48, and 60 ± 0.5 μg/mL). No treatment differences were observed in the fecal shedding of the Salmonella; however, we noted a tendency for a treatment difference in the percentage of calves positive for Salmonella present in the ileal tissue at d 21 after the challenge (25, 50, and 60%). Supplementing preweaned Holstein calves with both SC in milk replacer and XPC in calf starter improved starter intake and improved fecal consistency immediately after a mild Salmonella enterica challenge, but more data are needed to further understand how these yeast fermentation products influence the immune responses to Salmonella enterica.

Influence of supplementation of Saccharomyces cerevisiae fermentation product to horses on acquired immunity using a novel vaccine challenge

Influence of supplementation of Saccharomyces cerevisiae fermentation product to horses on acquired immunity using a novel vaccine challenge

Effects of Saccharomyces cerevisiae fermentation products on performance and rumen fermentation and microbiota in dairy cows fed a diet containing low quality forage

BackgroundA possible option to meet the increased demand of forage for dairy industry is to use the agricultural by-products, such as corn stover. However, nutritional value of crop residues is low and we have been seeking technologies to improve the value. A feeding trial was performed to evaluate the effects of four levels of Saccharomyces cerevisiae fermentation product (SCFP; Original XP; Diamond V) on lactation performance and rumen fermentation in mid-lactation Holstein dairy cows fed a diet containing low-quality forage. Eighty dairy cows were randomly assigned into one of four treatments: basal diet supplemented with 0, 60, 120, or 180 g/d of SCFP per head mixed with 180, 120, 60, or 0 g of corn meal, respectively. The experiment lasted for 10 wks, with the first 2 weeks for adaptation.ResultsDry matter intake was found to be similar (P > 0.05) among the treatments. There was an increasing trend in milk production (linear, P ≤ 0.10) with the increasing level of SCFP supplementation, with no effects on contents of milk components (P > 0.05). Supplementation of SCFP linearly increased (P < 0.05) the N conversion, without affecting rumen pH and ammonia-N (P > 0.05). Increasing level of SCFP linearly increased (P < 0.05) concentrations of ruminal total volatile fatty acids, acetate, propionate, and butyrate, with no difference in molar proportion of individual acids (P > 0.05). The population of fungi and certain cellulolytic bacteria (Ruminococcus albus, R. flavefaciens and Fibrobacter succinogenes) increased linearly (P < 0.05) but those of lactate-utilizing (Selenomonas ruminantium and Megasphaera elsdenii) and lactate-producing bacteria (Streptococcus bovis) decreased linearly (P ≤ 0.01) with increasing level of SCFP. The urinary purine derivatives increased linearly (P < 0.05) in response to SCFP supplementation, indicating that SCFP supplementation may benefit for microbial protein synthesis in the rumen.ConclusionsThe SCFP supplementation was effective in maintaining milk persistency of mid-lactation cows receiving diets containing low-quality forage. The beneficial effect of SCFP could be attributed to improved rumen function; 1) microbial population shift toward greater rumen fermentation efficiency indicated by higher rumen fungi and cellulolytic bacteria and lower lactate producing bacteria, and 2) rumen microbial fermentation toward greater supply of energy and protein indicated by greater ruminal VFA concentration and increased N conversion. Effects of SCFP were dose-depended and greater effects being observed with higher levels of supplementation and the effect was more noticeable during the high THI environment.

Effects of Saccharomyces cerevisiae fermentation products on the lactational performance of mid-lactation dairy cows.

This study was to evaluate 1 current and 2 newly developed Saccharomyces cerevisiae fermentation products (SCFP, Diamond V Original XPC and 2 test products) on the production efficiency of mid-lactation dairy cows. Eighty mid-lactation (164.5 ± 67.5 d in milk: DIM) Holstein cows (56 multiparous and 24 primiparous) were blocked by parity, DIM, and milk production, and randomly assigned to 1 of 4 treatments. Treatments consisted of: 1) Control (CON): corn silage and haylage based ration; 2) XPC: CON ration with Original XPC added at 14 g/d; 3) Product 1 (P1): CON ration with Product 1 added at 5 g/d; and 4) Product 2 (P2): CON ration with Product 2 added at 19 g/d. Treatments were blended with dried distillers grains and then mixed into a total mixed ration at 454 g/d. The first 14 d of the study (d–14 to 0) was for training cows to use the Calan door feeding system and cows were fed the CON ration during this period followed by an 8 wk continuous experimental period. Dry matter intakes were similar (P > 0.10) when cows were fed all treatments (25.7, 26.1, 25.1, and 26.2 kg/d for CON, XPC, P1, and P2, respectively). Milk production (33.3, 34.4, 35.5, and 36.8 kg/d) was improved (P < 0.05) for cows fed P2 compared to cows fed CON, with cows fed other treatments being intermediate and similar (P > 0.10). Feed efficiency (milk yield/dry matter intake) was improved (P < 0.05) for cows fed P1 and P2, compared to cows fed CON and XPC (1.30, 1.34, 1.49 and 1.41 kg/kg). Milk fat content was reduced (P < 0.05) for cows fed P2 (4.17, 3.93, 4.08, and 3.85%) compared to cows fed CON, with cows fed other treatments being intermediate (P > 0.10). Milk protein and lactose percentages were similar (P > 0.10) among treatments. Cows fed P2 had reduced (P < 0.05) molar proportion of ruminal acetate (63.8, 64.0, 63.1, and 62.3%) and greater (P < 0.05) propionate (18.9, 19.3, 19.7, and 20.6%) than cows fed other treatments. Supplementing a dairy ration with SCFP, such as P2, can improve milk production and feed efficiency of mid-lactation cows.

Immunomodulatory Effects of Saccharomyces cerevisiae Fermentation Product Supplementation on Immune Gene Expression and Lymphocyte Distribution in Immune Organs in Broilers.

A study was conducted to evaluate the molecular and cellular immunomodulatory effects of a Saccharomyces cerevisiae fermentation product (Original XPC, Diamond V) in broilers. Our lab has previously demonstrated that broilers fed XPC generate faster and stronger antigen-specific humoral immune responses to Newcastle disease virus (NDV) vaccination. This study aims at investigating the mechanism behind this increased immunocompetence. One-day-old broilers were randomly assigned to one of two treatments: 1.25 kg/ton S. cerevisiae fermentation product (XPC treatment group) or control diet. Birds were vaccinated against NDV on day 1 (B1 strain) and day 21 (LaSota strain) post-hatch. Innate and adaptive immune-related gene expression profiles in central (thymus and bursa of Fabricius) and peripheral (spleen) immune organs were investigated at 14 and 28 days of age by qPCR array. Fold changes larger than 1.2 (P < 0.05) between treated and control were considered significant. Lymphocyte subpopulations in central and peripheral immune organs and blood leukocytes were analyzed by flow cytometry at 14, 21, 28, and 42 days of age. In the spleen, Th1 immune responses and antiviral genes, such as IFN-γ, and its downstream genes signal transducer and activator of transcription (STAT4) and NFκB, were significantly upregulated in the treated group by 14 days of age. In the thymus, genes belonging to different functional groups were influenced at different time points. Cytokine genes associated with lymphocyte maturation, differentiation, and proliferation, such as IL-1R, IL-2, and IL-15 were significantly upregulated in the treated group by 28 days of age. Genes preferentially expressed in the medulla of the thymus and mature thymocytes, such as Myxovirus resistance gene 1, interferon regulatory factor-1, interferon regulatory factor-7, and STAT1, were upregulated in the birds supplemented with XPC. Birds supplemented with XPC had significantly higher percentages of CD3+, CD4+, and CD8+ T-cells in the thymus at day 28 of age, indicating production of more mature T-cells, which was consistent with gene expression results. Results suggest that XPC supplementation primes broilers to become more immunocompetent, without compromising growth performance.

Effects of dietary supplementation of Saccharomyces cerevisiae fermentation product to sows and their offspring on growth and meat quality.

This study evaluated the effects of long term dietary supplementation of Saccharomyces cerevisiae fermentation product (SCFP) in the diets for sows and offspring on growth performance, intestinal morphology, volatile fatty acid production, and carcass characteristics of offspring. Newly weaned pigs (n = 256) were allotted to 4 treatments based on a 2 × 2 factorial arrangement. Each treatment had 8 pens with 8 pigs per pen. First factor was maternal dietary effects (no SCFP, or SCFP at 12.0 and 15.0 g/d through gestation and lactation, respectively) and the second factor was dietary supplementation of SCFP to offspring (no SCFP, or SCFP at 0.2 and 0.1% for nursery and finisher, respectively). Pigs were on a 6-phase feeding program with assigned diets from nursery to slaughter. Body weights (BW) and feeder weights were measured at the end of each phase. On d 5 after weaning, 1 pig per pen was euthanized to evaluate intestinal morphology and volatile fatty acid production. At 115 kg of BW, 1 pig from each pen was slaughtered to measure carcass characteristics. Feeding diets with SCFP to sows or to their offspring had no effect on BW, overall average daily gain (ADG), average daily feed intake (ADFI), and gain-to-feed (G:F) ratio during the nursery or finisher period. Feeding SCFP to sows tended to increase (P = 0.098) cecal butyric acid production in their offspring. Pigs with SCFP tended to have a greater (P = 0.084) concentration of acetic acid but a reduced (P = 0.054) propionic acid in colon digesta than pigs without SCFP regardless of maternal feeding regimen. Loin marbling scores were greater (P = 0.043) in pigs with SCFP than those without SCFP regardless of maternal feeding regimen. Overall, supplementation of SCFP in sow diets did not affect growth performance or intestinal morphology of their offspring. Supplementation of SCFP in diets of offspring from nursery to slaughter had little effect on growth performance. However, inclusion of SCFP from nursery to slaughter improved marbling score possibly by increased acetic acid and butyric acid production in the large intestine.

Effects of Saccharomyces cerevisiae fermentation products on dairy calves: Performance and health

The aim of the study was to evaluate the effects of Saccharomyces cerevisiae fermentation products (SCFP) on performance and health of calves during the first 63 d of age. Sixty Holstein calves (30 males and 30 females) at 2 d of age were blocked by sex and date of birth then randomly assigned within blocks to 1 of 3 treatments. A texturized calf starter was fed ad libitum containing 0 (control), 0.5, or 1% SCFP (Original XPC, Diamond V, Cedar Rapids, IA) of DM. In addition, the supplemented calves were fed 1 g/d SCFP (SmartCare, Diamond V) in milk until d 30. All calves were fed 4 L of colostrum within 1 h of birth and were subsequently fed milk twice daily until weaned at 56 d of age. Male calves were harvested on d 56. Performance and health of weaned female calves were monitored until 63 d of age to determine the effect of preweaning treatment of SCFP on weaning stress. Starter intake, fecal scores, and medical treatments were recorded daily. Body weight measures and blood samples were collected on d 2, 28, 56, and 63. Serum was analyzed for blood urea nitrogen, fatty acids, insulin-like growth factor-1, glucose, and total protein. Oxidative biomarkers and total antioxidant capacity were also evaluated in the serum. Body weight, DMI, blood parameters, and oxidative biomarkers did not differ among treatments. Supplementation of SCFP lowered fecal scores in the pre- and postweaning periods. Saccharomyces cerevisiae fermentation products can be used to reduce the diarrhea in calves grown under normal commercial conditions.

1472 Effects of Saccharomyces cerevisiae fermentation products on intestinal villi integrity in neonatal calves naturally infected with Cryptosporidium spp

1472 Effects of Saccharomyces cerevisiae fermentation products on intestinal villi integrity in neonatal calves naturally infected with Cryptosporidium spp

0101 Influence of dietary supplementation with a Saccharomyces cerevisiae fermentation product prototype on the pathophysiological response to a combined intranasal bovine herpesvirus-1 and intratracheal Mannheimia haemolytica challenge in Holstein steers

0101 Influence of dietary supplementation with a Saccharomyces cerevisiae fermentation product prototype on the pathophysiological response to a combined intranasal bovine herpesvirus-1 and intratracheal Mannheimia haemolytica challenge in Holstein steers

0102 Dose response effect of Saccharomyces cerevisiae fermentation product prototype on leukocyte functionality and ex vivo cytokine production during a dexamethasone challenge in Holsteins steer calves

0102 Dose response effect of Saccharomyces cerevisiae fermentation product prototype on leukocyte functionality and ex vivo cytokine production during a dexamethasone challenge in Holsteins steer calves

Effects of 3 sequestering agents on milk aflatoxin M1 concentration and the performance and immune status of dairy cows fed diets artificially contaminated with aflatoxin B1

This study examined whether adding 3 mycotoxin-sequestering agents to diets contaminated with aflatoxin B1 (AFB1) would reduce milk aflatoxin M1 (AFM1) concentration, and improve the performance and alter immune status of dairy cows. Fifteen lactating dairy cows were used in an experiment with an incomplete crossover design including four 28-d periods. Treatments included a control diet (C), a toxin diet (T; 1,725µg of AFB1/head per day; 75µg/kg), and diets containing the toxin and 20g/head per day of a proprietary mixture of Saccharomyces cerevisiae fermentation product containing a low (SEQ1) or high (SEQ2) dose of a chlorophyll-based additive, or a low dose of the chlorophyll-based additive and sodium bentonite clay (SEQ3). Sequestering agents were top-dressed on the total mixed ration (TMR) daily in each period, and AFB1 was dosed orally in gelatin capsules before the TMR was fed on d 21 to 25. Milk was sampled twice daily on d 20 to 28 and plasma was sampled on d 20 and 25. Sequestering agents did not affect milk AFM1 concentration during the toxin-dosing period. However, after AFB1 was withdrawn, the sequestering agents reduced the time required (24 vs. 48h) to reduce the milk AFM1 concentration below the Food and Drug Administration action level of 0.5µg/kg. Feeding T instead of C tended to reduce milk and fat-corrected milk yields, but feeding SEQ1 prevented these effects. Red blood cell count and hemoglobin concentration were reduced by feeding T instead of C, but not by feeding SEQ1, SEQ2, or SEQ3. The mean fluorescence intensity of antibody staining for 2 leukocyte adhesion molecules, L-selectin (CD62L) and β-integrin (CD18), tended to be greatest when SEQ1 and SEQ3 were fed. Plasma acid-soluble protein concentration was decreased by feeding SEQ1, SEQ2, and SEQ3 instead of T. Sequestering agents had no effect on milk AFM1 concentration, but they reduced the time required to reduce milk AFM1 concentration to a safe level after withdrawal of AFB1 from the diet. Only SEQ1 prevented the adverse effects of AFB1 on milk and fat-corrected milk yields.

PS130 Elevated Neutrophils, Monocytes and White Cell Counts in Patients With Myocardial Infarction Compared With Stable Coronary Artery Disease

This study was designed to investigate the effects of supplementing SmartCare (SC; Diamond V, Cedar Rapids, IA) in milk replacer and Original XPC (XPC; Diamond V) in calf starter on performance and health of preweaned calves following an oral challenge with Salmonella enterica. The study was performed in two 35-d periods with 30 Holstein bull calves (2 ± 1 d of age) per period. In each period, calves were blocked by location in the barn and randomly assigned to treatments that included control, base milk replacer and calf starter with no added Saccharomyces cerevisiae fermentation products; SC, milk replacer with 1 g of SC/calf per day and base calf starter; and SC+XPC, milk replacer with 1 g of SC/calf per day and calf starter with 0.5% XPC on a dry matter basis. Calves were fed 350 g of milk replacer solids at 14% dry matter twice daily at 0700 and 1700 h. Calf starter and water were offered ad libitum and intakes were recorded daily. Calves were challenged with 108 cfu of sulfamethazine-resistant Salmonella enterica serotype Typhimurium orally on d 14 of the study. Fecal Salmonella shedding was determined on d 14 to 21 (daily), 24, 28, and 35 using selective media. Blood samples were collected on d 0, 7, 14, 16, 18, 21, 24, 28, and 35 and analyzed for hematology; plasma were analyzed for haptoglobin concentrations. All data were reported as CON, SC, and SC+XPC, respectively. Calf starter intake was increased from d 22 to 35 among SC+XPC calves and from d 29 to 35 among SC calves. The SC+XPC calves had a lower neutrophil-to-lymphocyte ratio (0.81, 0.83, and 0.69 ± 0.051) throughout the study. The SC+XPC calves also had lower hematocrits (35.1, 35.3, and 33.4 ± 0.54%) and hemoglobin concentrations (10.8, 10.6, and 10.1 ± 0.16 mg/dL) throughout the study. We found a tendency for calves fed SC and SC+XPC to have more solid fecal scores during the week after the challenge. We observed no treatment or treatment × time differences on plasma haptoglobin concentrations (63, 48, and 60 ± 0.5 μg/mL). No treatment differences were observed in the fecal shedding of the Salmonella; however, we noted a tendency for a treatment difference in the percentage of calves positive for Salmonella present in the ileal tissue at d 21 after the challenge (25, 50, and 60%). Supplementing preweaned Holstein calves with both SC in milk replacer and XPC in calf starter improved starter intake and improved fecal consistency immediately after a mild Salmonella enterica challenge, but more data are needed to further understand how these yeast fermentation products influence the immune responses to Salmonella enterica.

Effects of Saccharomyces cerevisiae fermentation products on dairy calves: Ruminal fermentation, gastrointestinal morphology, and microbial community

The aim of this study was to evaluate the effects of Saccharomyces cerevisiae fermentation products (SCFP) in the calf starter and milk on ruminal fermentation, gastrointestinal morphology, and microbial community in the first 56 d of life. Thirty Holstein bull calves were randomly assigned to 1 of 3 groups: a texturized calf starter containing 0 (CON), 0.5, or 1% SCFP (XPC, Diamond V, Cedar Rapids, IA) of dry matter from d 4 to 56. In addition, the XPC-supplemented calves were fed with 1 g/d SCFP (SmartCare, Diamond V, Cedar Rapids, IA) in milk from d 2 to 30. All calves were fed 4 L of colostrum within 1 h of birth and were subsequently fed milk twice daily until weaned on d 56. Rumen fluid was collected by an esophageal tube 4 h after the morning feeding on d 28 and 56 to determine ruminal pH, ammonia-N, and volatile fatty acids concentrations. On d 56, 15 (5 per treatment) calves were harvested and slaughter weight, gastrointestinal morphology parameters, and bacteria community were recorded. Papilla length, width, and surface area were measured from 5 locations within the rumen. Villus height, width, surface area, crypt depth, and villus height-to-crypt depth ratio were measured in the duodenum, jejunum, and ileum. Next-generation sequencing technology was used to test the microbial community of the rumen and duodenum samples on d 28 and 56. Data were analyzed by MIXED procedure in SAS (SAS Institute Inc., Cary, NC) with contrast statements to declare CON versus all SCFP and 0.5 versus 1% SCFP in starter grains. Ruminal pH, ammonia-N, and total volatile fatty acids were not altered by SCFP. However, the supplemented groups exhibited higher ruminal butyrate concentrations coinciding with higher Butyrivibrio and lower Prevotella richness than CON group. Supplementation of SCFP increased papilla length in the rumen. In the small intestine, SCFP reduced crypt depth of jejunum, and increased villus height-to-crypt depth ratio in all segments of the small intestine, especially when supplemented at a higher dosage in the starter. In conclusion, Saccharomyces cerevisiae fermentation products improved gastrointestinal morphology, possibly due to increased Butyrivibrio and decreased Prevotella richness of the rumen fluid, which resulted in an increase in butyrate production, and the effect was slightly greater with the higher dosage of SCFP in the starter.

Meta-analysis examining the effects of Saccharomyces cerevisiae fermentation products on feedlot performance and carcass traits

ABSTRACT Results from 18 experiments were compiled for a meta-analysis evaluating the effects of Saccharomyces cerevisiae fermentation products (SCFP) manufactured by Diamond V on feedlot performance and carcass traits. Data were analyzed using mixed model procedures. Fixed class variables included sex (steers, heifers, bulls, or mixed) and the use of SCFP, ionophores, tylosin, and implants (each coded as no = 0, yes = 1). Days on feed and initial BW were included in models as fixed continuous variables when significant ( P ≤ 0.05). Experiment was included in all models as a random class variable. The analysis was weighted by the inverse of the standard error squared for each treatment mean. Cattle fed SCFP had significant ( P P P P P

295 Effects of tribasic copper chloride (TBCC), Saccharomyces cerevisiae fermentation product (YFP), and narasin (NAR) supplementation on growth performance of 12 to 25 kg pigs

295 Effects of tribasic copper chloride (TBCC), Saccharomyces cerevisiae fermentation product (YFP), and narasin (NAR) supplementation on growth performance of 12 to 25 kg pigs

286 Effect of Saccharomyces cerevisiae fermentation product supplementation in late gestation and lactation on sow and litter performance, milk components, and fecal Clostridium perfringens

286 Effect of Saccharomyces cerevisiae fermentation product supplementation in late gestation and lactation on sow and litter performance, milk components, and fecal Clostridium perfringens